These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. Motallebzadeh R; Rehakova S; Conlon TM; Win TS; Callaghan CJ; Goddard M; Bolton EM; Ruddle NH; Bradley JA; Pettigrew GJ FASEB J; 2012 Jan; 26(1):51-62. PubMed ID: 21926237 [TBL] [Abstract][Full Text] [Related]
3. Characterisation of Tertiary Lymphoid Organs in Explanted Rejected Donor Kidneys. Xu X; Han Y; Wang Q; Cai M; Qian Y; Wang X; Huang H; Xu L; Xiao L; Shi B Immunol Invest; 2016; 45(1):38-51. PubMed ID: 26709668 [TBL] [Abstract][Full Text] [Related]
5. Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. Nasr IW; Reel M; Oberbarnscheidt MH; Mounzer RH; Baddoura FK; Ruddle NH; Lakkis FG Am J Transplant; 2007 May; 7(5):1071-9. PubMed ID: 17359505 [TBL] [Abstract][Full Text] [Related]
6. B Cell Activating Factor (BAFF) Is Required for the Development of Intra-Renal Tertiary Lymphoid Organs in Experimental Kidney Transplantation in Rats. Steines L; Poth H; Herrmann M; Schuster A; Banas B; Bergler T Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126753 [TBL] [Abstract][Full Text] [Related]
7. The composition of ectopic lymphoid structures suggests involvement of a local immune response in cardiac allograft vasculopathy. Huibers MM; Gareau AJ; Vink A; Kruit R; Feringa H; Beerthuijzen JM; Siera-de Koning E; Peeters T; de Jonge N; de Weger RA; Lee TD J Heart Lung Transplant; 2015 May; 34(5):734-45. PubMed ID: 25655346 [TBL] [Abstract][Full Text] [Related]
8. Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs. Wagnetz D; Sato M; Hirayama S; Matsuda Y; Juvet SC; Yeung JC; Guan Z; Zhang L; Liu M; Waddell TK; Keshavjee S Transplantation; 2012 Jun; 93(12):1212-20. PubMed ID: 23318304 [TBL] [Abstract][Full Text] [Related]
9. Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction. Mineura K; Tanaka S; Goda Y; Terada Y; Yoshizawa A; Umemura K; Sato A; Yamada Y; Yutaka Y; Ohsumi A; Nakajima D; Hamaji M; Mennju T; Kreisel D; Date H Am J Transplant; 2024 Jun; 24(6):944-953. PubMed ID: 38403187 [TBL] [Abstract][Full Text] [Related]
10. The Role of Lymphoid Neogenesis in Allografts. Hsiao HM; Li W; Gelman AE; Krupnick AS; Kreisel D Am J Transplant; 2016 Apr; 16(4):1079-85. PubMed ID: 26614734 [TBL] [Abstract][Full Text] [Related]
11. Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection. Brown K; Sacks SH; Wong W Eur J Immunol; 2011 Jan; 41(1):89-96. PubMed ID: 21182080 [TBL] [Abstract][Full Text] [Related]
12. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts. Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816 [TBL] [Abstract][Full Text] [Related]
13. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [TBL] [Abstract][Full Text] [Related]
14. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Baddoura FK; Nasr IW; Wrobel B; Li Q; Ruddle NH; Lakkis FG Am J Transplant; 2005 Mar; 5(3):510-6. PubMed ID: 15707405 [TBL] [Abstract][Full Text] [Related]
15. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection. Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624 [TBL] [Abstract][Full Text] [Related]
16. Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A. Luo R; Cheng Y; Chang D; Liu T; Liu L; Pei G; Zhang N; Wang Z; Guo K; Chen W; Li M; Fan L; Zhang C; Li Y; Dai W; Zuo M; Xu Y; Yao Y; Ge S; Xu G Theranostics; 2021; 11(1):117-131. PubMed ID: 33391465 [No Abstract] [Full Text] [Related]
17. Secondary lymphoid organs are important but not absolutely required for allograft responses. Zhou P; Hwang KW; Palucki D; Kim O; Newell KA; Fu YX; Alegre ML Am J Transplant; 2003 Mar; 3(3):259-66. PubMed ID: 12614279 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes. Korpos É; Kadri N; Loismann S; Findeisen CR; Arfuso F; Burke GW; Richardson SJ; Morgan NG; Bogdani M; Pugliese A; Sorokin L Diabetologia; 2021 Jul; 64(7):1626-1641. PubMed ID: 33912981 [TBL] [Abstract][Full Text] [Related]
19. Characterizing the B-Cell and Humoral Response in Tertiary Lymphoid Organs in Kidney Allografts. Nowocin AK; Meader L; Brown K; Elgueta R; Wong W Exp Clin Transplant; 2019 Jun; 17(3):330-338. PubMed ID: 30880652 [TBL] [Abstract][Full Text] [Related]
20. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. Thaunat O; Patey N; Gautreau C; Lechaton S; Fremeaux-Bacchi V; Dieu-Nosjean MC; Cassuto-Viguier E; Legendre C; Delahousse M; Lang P; Michel JB; Nicoletti A Transplantation; 2008 Jun; 85(11):1648-53. PubMed ID: 18551073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]